FitLife Brands director buys 3,000 shares

FITLIFE BRANDS, INC. director Matthew Lingenbrink made an open-market purchase of the company’s common stock.

Rhea-AI Filing Summary

FITLIFE BRANDS, INC. director Matthew Lingenbrink made an open-market purchase of the company’s common stock. On April 10, 2026, he bought 3,000 shares at $9.76 per share, increasing his direct holdings to 8,800 shares. According to a footnote, the purchase followed Board approval to temporarily extend the trading window under the company’s Insider Trading Policy after disclosure of the expected range of operating results for the quarter ending March 31, 2026 and confirmation that there was no undisclosed material information.

Insider Trade Summary

Net Buyer: 3,000 shares

Net Buy 1 txn

Insider Lingenbrink Matthew

Role Director

Bought 3,000 shs ($29K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	3,000	$9.76	$29K

Holdings After Transaction: Common Stock — 8,800 shares (Direct)

Footnotes (1)

1. F1. The shares were purchased following approval by the Board of Directors to temporarily extend the trading window under the Company's Insider Trading Policy, given the disclosure by the Company of the expected range of operating results for the quarter ending March 31, 2026 and the absence of undisclosed material information.

Key Figures

Shares purchased: 3,000 shares Purchase price: $9.76 per share Shares held after: 8,800 shares +1 more

4 metrics

Shares purchased 3,000 shares Open-market purchase on April 10, 2026

Purchase price $9.76 per share Common Stock transaction

Shares held after 8,800 shares Total direct holdings following transaction

Net buy shares 3,000 shares Net-buy direction in transaction summary

Key Terms

open-market purchase, Insider Trading Policy, trading window, undisclosed material information

4 terms

open-market purchase financial

"transaction_action: "open-market purchase" of Common Stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Insider Trading Policy regulatory

"extended the trading window under the Company's Insider Trading Policy"

A written set of rules that tells employees, executives and board members what information they may not use to buy or sell a company's stock and when trading is allowed. Think of it as a playbook or house rules that prevent people with secret knowledge from getting an unfair advantage; it matters to investors because it helps protect fair markets, preserves trust in management, and reduces the risk of legal penalties that can hurt a company’s value.

trading window financial

"approval by the Board of Directors to temporarily extend the trading window"

A trading window is a designated time period when company insiders and certain employees are allowed to buy or sell the company’s stock under internal policies and securities rules. Like a store’s open hours, it creates a predictable, legal opportunity for insiders to trade without using confidential information; investors watch these trades for clues about insider confidence and to be reassured that the company is following rules that reduce legal and reputational risk.

undisclosed material information regulatory

"and the absence of undisclosed material information"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FTLF director Matthew Lingenbrink report?

Director Matthew Lingenbrink reported an open-market purchase of 3,000 shares of FITLIFE BRANDS, INC. common stock. The transaction occurred on April 10, 2026 and reflects a direct increase in his personal share ownership in the company.

At what price did the FTLF director buy shares and how many does he now hold?

Matthew Lingenbrink bought 3,000 FITLIFE BRANDS, INC. common shares at a price of $9.76 per share. Following this transaction, his total direct holdings increased to 8,800 shares of the company’s common stock.

How did FITLIFE BRANDS, INC. handle insider trading policy for this Form 4 trade?

The purchase was made after the Board of Directors approved a temporary extension of the trading window under the Insider Trading Policy. This followed disclosure of the expected range of operating results and confirmation that no undisclosed material information existed.

Why was the trading window extended for the FTLF insider purchase?

The trading window was temporarily extended because the company had disclosed the expected range of operating results for the quarter ending March 31, 2026. The Board also noted the absence of any undisclosed material information before allowing the transaction.

Is the FTLF director’s transaction classified as a buy or sell in this Form 4?

The transaction is classified as a buy, specifically an open-market purchase of common stock. The Form 4 data show one purchase transaction, no sales, and a net-buy direction of 3,000 shares in the reporting period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lingenbrink Matthew

(Last) (First) (Middle)

C/O FITLIFE BRANDS, INC.

5214 S. 136TH STREET

(Street)

OMAHA NEBRASKA 68137

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FITLIFE BRANDS, INC. [ FTLF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/10/2026		P(1)		3,000	A	$9.76	8,800	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were purchased following approval by the Board of Directors to temporarily extend the trading window under the Company's Insider Trading Policy, given the disclosure by the Company of the expected range of operating results for the quarter ending March 31, 2026 and the absence of undisclosed material information.

	/s/ Matthew Lingenbrink	04/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)